InnovaPuglia Awards €82.9 Million Home Oxygen Therapy Contracts

Standfirst

InnovaPuglia has awarded four regional contracts for home oxygen therapy services across Puglia's health authorities to Linde Medicale, SICO and Nippon Sanso Pharma, with a combined value of roughly EUR 82.9 million against an original estimate of EUR 158.9 million. Every one of the four lots was won at close to half its budgeted value, a striking and consistent pattern across the whole tender.

Introduction

For patients with chronic respiratory conditions who need supplemental oxygen at home rather than in hospital, home oxygen therapy is not a convenience, it is often what allows them to live outside a clinical setting at all. Puglia's regional health system has just secured that service for its entire population, splitting the work into four geographic zones covering the region's local health authorities.

Three companies, all major names in industrial and medical gas supply, Linde Medicale, SICO and Nippon Sanso Pharma, will now deliver that care. What stands out beyond the winners themselves is the price: every single lot was awarded at roughly half its original estimated value, a consistency worth examining closely.

Why This Contract Matters

Home oxygen therapy sits at the intersection of medical equipment supply and direct patient care, requiring not just oxygen concentrators or cylinders but ongoing logistics, delivery, equipment maintenance and clinical support delivered directly into patients' homes across an entire region. Structuring this as four geographic lots, rather than one region wide contract, lets Puglia's health system match local delivery capacity to each area's specific patient population.

The scale of the savings achieved here, roughly EUR 76 million below the original combined estimate across all four lots, is also worth understanding. Whether this reflects genuinely intense competition, a systematically conservative original budget, or something specific to how this therapy is priced and reimbursed, the gap between estimate and outcome is large enough to be the central story of this procurement.

Contract Timeline

• Winners selected: 14 May 2026, all four lots
• Notice dispatched to the Publications Office: 2 September 2026
• Published in the Official Journal, OJ S 171/2026: 4 September 2026, as notice version 08

Contract Overview

InnovaPuglia S.p.A. ran an open procedure for home oxygen therapy services across Puglia, split into four lots by geographic area, each aligned to specific local health authorities. The combined estimated value across all four lots was EUR 158 904 310.21. The four winning tenders together came to approximately EUR 82 912 562.46, meaning every lot was awarded at close to half its original estimated value.

Key Contract Details

Project Scope

The four lots divide Puglia's home oxygen therapy service by geography: a North area covering the local health authorities of Barletta-Andria-Trani and Foggia; a Centre 1 area covering Bari; a Centre 2 area covering Brindisi and Taranto; and a South area covering Lecce. Together, the four lots span the full territorial reach of Puglia's regional health system, ensuring every part of the region has a designated home oxygen therapy provider.

About the Contracting Authority

InnovaPuglia S.p.A. is a regional authority based in Puglia, southern Italy, acting as the region's in-house company for coordinating procurement and innovation on behalf of Puglia's public administration, including its regional health system.

About the Organisations Involved

InnovaPuglia S.p.A.

As covered above, InnovaPuglia is the buyer running this regional tender on behalf of Puglia's health authorities.

Linde Medicale

Linde Medicale, based in Arluno near Milan, won Lot 1, the North area covering Barletta-Andria-Trani and Foggia, with a winning bid of EUR 15 449 799.54. Linde Medicale operates as the medical gas division of Linde, one of the world's largest industrial gas companies, with a substantial home healthcare and medical gas supply business across Italy.

SICO Società Italiana Carburo Ossigeno S.p.A.

SICO, based in Milan, won two of the four lots: Lot 2, the Centre 1 area covering Bari, worth EUR 24 051 310.23 and Lot 4, the South area covering Lecce, worth EUR 21 852 314.28, making it the largest single winner in this tender by combined value, at just under EUR 46 million.

Nippon Sanso Pharma S.r.l.

Nippon Sanso Pharma, based in Milan, won Lot 3, the Centre 2 area covering Brindisi and Taranto, with a winning bid of EUR 21 559 138.41. The company is the Italian pharmaceutical gas arm of Nippon Sanso Holdings, a major Japanese industrial gas group with global operations.

Procurement Analysis

The consistency of the savings across all four lots is the defining feature of this tender. Lot 1 was awarded at roughly 53 percent of its estimate, Lot 2 at roughly 52 percent, Lot 3 at roughly 51 percent and Lot 4 at roughly 52 percent, an unusually tight clustering that suggests something systematic rather than coincidental. This could reflect a shared understanding among bidders of the service's true cost structure, a standard reimbursement or tariff based pricing model common in Italian regional healthcare service contracts where the original estimate may have been built on conservative assumptions, or simply strong, well informed competition among a small number of specialist suppliers who know this market precisely.

The fact that this notice has been published as its eighth version indicates a lengthy administrative history, with multiple prior corrections or updates to the record before reaching this current, presumably final, state.

Additional Procurement Facts

• All four lots are geographically distinct, ensuring dedicated provider coverage across every part of Puglia's regional health system.
• Three separate companies won across the four lots, with SICO securing two, avoiding full market concentration with a single supplier.
• All four winners were selected on the same date, indicating a coordinated evaluation process across the full tender.

Market and Industry Perspective

Home oxygen therapy and medical gas supply in Italy is dominated by a small number of large, often multinational, industrial gas companies with the logistics infrastructure needed to deliver oxygen equipment and support directly to patients' homes at regional scale. Linde, SICO and Nippon Sanso Pharma's presence here reflects that concentrated market structure, where genuine competition exists among a handful of credible national and international players rather than a broad field of smaller local providers.

Economic Significance

At a combined awarded value of roughly EUR 82.9 million, spread across four regional contracts, this is a substantial, recurring investment in home based respiratory care for Puglia's patient population, delivering meaningful savings against the original budget while securing dedicated provider coverage across the entire region.

Future Procurement Opportunities

Given the multi-year nature typical of home healthcare service contracts of this kind, further recompetes are likely once current terms conclude, offering other medical gas and home healthcare providers a future opportunity to compete for Puglia's regional oxygen therapy business.

Opportunities for Suppliers

Medical gas and home healthcare service providers should note the geographic lot structure demonstrated here as a common model in Italian regional healthcare procurement, allowing suppliers to focus bidding resources on specific territories matched to their existing logistics footprint rather than needing to cover an entire region.

What Businesses Should Watch

• Whether the significant gap between estimated and awarded value across all four lots reflects a broader pattern in Italian regional healthcare service tendering.
• Service delivery performance across the four geographic areas as the new contracts take effect.
• Future InnovaPuglia tenders for related home healthcare or medical equipment services.

ItalyTenders.com Procurement Intelligence

The consistent, roughly 50 percent gap between estimated and awarded value across all four lots in this tender is the detail worth remembering. When every lot in a multi-lot tender lands at a similar discount to its estimate, it points toward a structural feature of the market or the pricing model, not chance and businesses tracking Italian regional healthcare procurement should watch for whether this pattern recurs in comparable future tenders, since it may indicate that original budget estimates in this specific service category are consistently set well above what genuine competition ultimately delivers.

For medical gas and home healthcare suppliers, the fact that three companies split four lots, rather than one company sweeping the entire region, suggests genuine competitive dynamics persist even in a market dominated by a small number of large multinational players, offering a meaningful opening for well positioned specialists to secure regional footholds.

Supplier Takeaways

• All four lots in this tender were awarded at close to half their original estimated values, a striking and consistent pattern worth understanding before bidding into similar future tenders.
• Three different suppliers won across four lots, showing genuine competitive distribution rather than single supplier dominance.
• Geographic lot structures matched to specific local health authorities are a common and effective way to compete for regional shares of large healthcare service contracts.
• This notice's eighth version status reflects a lengthy administrative correction history, a reminder to check for the most current version before relying on any single publication.

Key Takeaways

• InnovaPuglia awarded four regional home oxygen therapy contracts worth a combined EUR 82.9 million, against an original estimate of EUR 158.9 million.
• Winners are Linde Medicale, SICO (two lots) and Nippon Sanso Pharma.
• Every lot was awarded at roughly half its estimated value, a consistent pattern across the entire tender.
• The four lots cover Puglia's full territory, split by local health authority groupings.
• All winners were selected on the same date, 14 May 2026.
• This notice has been revised multiple times, now published as its eighth version.

Conclusion

Behind the routine language of a regional healthcare services tender sits a genuinely striking pricing story: four separate contracts, four separate winners and every single one landing at almost exactly half its original budget. For patients across Puglia who depend on oxygen therapy to stay safely at home, the practical outcome is straightforward, dedicated providers now cover every corner of the region. For anyone tracking how Italian healthcare tenders are priced, the consistency of that discount is the detail worth watching closest.

Source: Tenders Electronic Daily (TED), Contract Award Notice 612151-2026, Official Journal of the European Union, OJ S 171/2026, published on 4 September 2026.